The Queen Elizabeth Hospital Birmingham is a major, 1,215 bed, tertiary NHS and military hospital in the Edgbaston area of Birmingham, situated very close to the University of Birmingham.

There are 1,215 beds in Queen Elizabeth Hospital.

During the past decade, Queen Elizabeth Hospital conducted 353 clinical trials. In the 10-year time frame, 353 clinical trials started and 119 clinical trials were completed, i.e. on average, 33.7% percent of trials that started reached the finish line to date. In the past 5 years, 106 clinical trials started and 63 clinical trials were completed. i.e. 59.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 sponsor was "University of Birmingham" with 38 trials, followed by "University Hospital Birmingham NHS Foundation Trust" with 23 trials sponsored, "Gilead Sciences" with 15 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "University College, London" with 15 trials sponsored. Other sponsors include 468 different institutions and companies that sponsored additional 269 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital" #1 collaborator was "Cancer Research UK" with 25 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 15 trials as a collaborator, "University of Birmingham" with 15 trials as a collaborator, "University Hospital Birmingham NHS Foundation Trust" with 12 trials as a collaborator and "British Heart Foundation" with 11 trials as a collaborator. Other collaborators include 599 different institutions and companies that were collaborators in the rest 411 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital" are "Multiple Myeloma" (15 trials), "Heart Failure" (12 trials), "Breast Cancer" (11 trials), "Cystic Fibrosis" (10 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "Queen Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth Hospital" are "Drug" (339 trials), "Other" (86 trials), "Biological" (73 trials), "Procedure" (60 trials) and "Device" (55 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (90 trials), "Cyclophosphamide" (12 trials), "Dexamethasone" (12 trials), "Bortezomib" (10 trials) and "Lenalidomide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth Hospital" are 539 trials for "All" genders, 20 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 186 active trials in "Queen Elizabeth Hospital". 4 are not yet recruiting, 106 are recruiting, 72 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 266 completed trials in Queen Elizabeth Hospital, 2 suspended trials, and 51 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth Hospital, 61 "Phase 1" clinical trials were conducted, 176 "Phase 2" clinical trials and 184 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 30 trials, and there were also 76 trials that are defined as “Not Applicable".

Queen Elizabeth Hospital has several departments that took part in Clinical trials: "Birmingham Heartlands Hospital" - 186 trials, "Diabetes Centre, Heartlands Hospital" - 4 trials, "Birmingham Heartlands and Solihull NHS Trust (Teaching)" - 6 trials, "Birmingham Heartlands Hospital ( Site 1910)" - 2 trials, "Renal Unit, Birmingham Heartlands Hospital" - 2 trials